These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4910386)
1. [Treatment of chronic myeloid leukemia and lymphoreticular sarcoma with piposulfan]. Schmidt M; Havemann K Dtsch Med Wochenschr; 1970 May; 95(21):1166-70. PubMed ID: 4910386 [No Abstract] [Full Text] [Related]
2. [Effect of piposulfan (ancyte) in malignant lymphomas and solid tumors]. Kenis Y Acta Clin Belg; 1968; 23(2):103-13. PubMed ID: 4914032 [No Abstract] [Full Text] [Related]
3. [Association of chronic myeloid leukemia and lymph node sarcoma. Study of 2 additional cases]. André R; Duhamel G; Najman A; Gorin N Nouv Rev Fr Hematol; 1972; 12(3):301-15. PubMed ID: 4266203 [No Abstract] [Full Text] [Related]
4. [Serious hematological accidents due to Myleran in the treatment of chronic myeloid leukemia]. Olmer J; Muratore R; Gabriel B; Canu AM Mars Med; 1968; 105(4):330-8. PubMed ID: 5245481 [No Abstract] [Full Text] [Related]
5. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases]. Larrain C; Cruz A; Codoceo V Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227 [No Abstract] [Full Text] [Related]
6. [Aplastic syndrome in myleran overdose]. Albrecht M; Tackmann W; Pribilla W Med Klin; 1971 Jan; 66(4):126-30. PubMed ID: 5278287 [No Abstract] [Full Text] [Related]
7. Results in the treatment of chronic myeloid leukaemia. Nasr AL; Aboul-Enein M; Tawfik HN Haematologica; 1972 Apr; 57(11):794-802. PubMed ID: 4200314 [No Abstract] [Full Text] [Related]
8. Chronic myeloid leukaemia: course, life expectancy, and an analysis of dibromomannitol and busulfan treatment. Gerhartz H Haematologica; 1972 Apr; 57(11):775-86. PubMed ID: 4200312 [No Abstract] [Full Text] [Related]
9. Effect of piposulfan (NSC-47774) on malignant lymphomas and solid tumors. Kenis Y Cancer Chemother Rep; 1968 Apr; 52(3):433-9. PubMed ID: 5244316 [No Abstract] [Full Text] [Related]
10. [Treatment of Vaquez's polycythemia with 1-4, bis-3-bromopropionyl-piperazine. Study of 36 cases]. Bilski-Pasquier G; Blanc CM; Bousser J Presse Med (1893); 1968 Oct; 76(41):1953-6. PubMed ID: 5248051 [No Abstract] [Full Text] [Related]
11. [Chronic myeloid leukaemia. Clinical study and analysis of therapeutical results in 55 cases]. Lamas S; Sanjuán I; Zabala P; Millán I; Cabrera R; Barbolla L; Menéndez J; Fernández MN Sangre (Barc); 1982; 27(4A):493-507. PubMed ID: 6961564 [No Abstract] [Full Text] [Related]
12. [Aplasia caused by busulfan in chronic myeloid leukemia]. Perol C; Najean Y; Tanzer J; Jacquillat C; Boiron M; Bernard J Nouv Rev Fr Hematol; 1967; 7(6):884-9. PubMed ID: 4230381 [No Abstract] [Full Text] [Related]
13. [Rehabilitation and cure of patients with hemoblastoses]. Gerhartz H Dtsch Med J; 1968 Mar; 19(5):161-3. PubMed ID: 4887782 [No Abstract] [Full Text] [Related]
14. [Preliminary results of myelobromol treatment of chronic granulocytic leukemia]. Urasiński I; Mysik M Wiad Lek; 1971 Jul; 24(3):271-4. PubMed ID: 5279032 [No Abstract] [Full Text] [Related]
16. [Recent developments in the treatment of chronic myeloid leukemia]. Herrmann R Med Klin; 1980 Aug; 75(18):645-9. PubMed ID: 6106883 [No Abstract] [Full Text] [Related]